Akoya Biosciences, Inc. financial data

Location
Marlborough, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2025 - 13 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 156% % -53%
Quick Ratio 49% % -8.5%
Debt-to-equity 1260% % 478%
Return On Equity -506% % -310%
Return On Assets -37% % 4.2%
Operating Margin -48% % 27%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49,875,399 shares 0.99%
Common Stock, Shares, Outstanding 49,836,931 shares 1%
Entity Public Float $61,700,000 USD
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 49,664,515 shares 0.97%
Weighted Average Number of Shares Outstanding, Diluted 49,664,515 shares 0.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $79,961,000 USD -15%
Cost of Revenue $30,591,000 USD -26%
Research and Development Expense $19,748,000 USD -18%
Operating Income (Loss) $38,557,000 USD 38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $47,402,000 USD 30%
Income Tax Expense (Benefit) $131,000 USD 77%
Net Income (Loss) Attributable to Parent $47,533,000 USD 30%
Earnings Per Share, Basic -1 USD/shares 32%
Earnings Per Share, Diluted -1 USD/shares 32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $20,357,000 USD 56%
Marketable Securities, Current $7,187,000 USD -85%
Cash, Cash Equivalents, and Short-term Investments $27,544,000 USD -55%
Accounts Receivable, after Allowance for Credit Loss, Current $11,742,000 USD -13%
Inventory, Net $22,853,000 USD -0.59%
Other Assets, Current $4,073,000 USD 7.4%
Assets, Current $66,212,000 USD -35%
Property, Plant and Equipment, Net $6,920,000 USD -23%
Operating Lease, Right-of-Use Asset $3,859,000 USD -31%
Intangible Assets, Net (Excluding Goodwill) $13,845,000 USD -17%
Goodwill $18,262,000 USD 0%
Other Assets, Noncurrent $437,000 USD -33%
Assets $112,649,000 USD -27%
Accounts Payable, Current $10,291,000 USD -4.2%
Employee-related Liabilities, Current $3,051,000 USD -26%
Accrued Liabilities, Current $11,572,000 USD -7.1%
Contract with Customer, Liability, Current $6,518,000 USD -1.4%
Liabilities, Current $108,082,000 USD 226%
Contract with Customer, Liability, Noncurrent $2,782,000 USD -5%
Deferred Income Tax Liabilities, Net $140,000 USD 87%
Operating Lease, Liability, Noncurrent $3,406,000 USD -40%
Other Liabilities, Noncurrent $40,000 USD
Liabilities $118,538,000 USD -2.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,000 USD 94%
Retained Earnings (Accumulated Deficit) $301,088,000 USD -19%
Stockholders' Equity Attributable to Parent $5,889,000 USD -118%
Liabilities and Equity $112,649,000 USD -27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,214,000 USD 65%
Net Cash Provided by (Used in) Financing Activities $250,000 USD 44%
Net Cash Provided by (Used in) Investing Activities $16,044,000 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 49,836,931 shares 1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,580,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21,045,000 USD 53%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,122,000 USD -5.4%
Deferred Tax Assets, Valuation Allowance $63,073,000 USD 23%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $64,647,000 USD 21%
Operating Lease, Liability $6,114,000 USD -27%
Payments to Acquire Property, Plant, and Equipment $204,000 USD -75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $47,518,000 USD 30%
Lessee, Operating Lease, Liability, to be Paid $6,818,000 USD -30%
Property, Plant and Equipment, Gross $18,965,000 USD 4.8%
Operating Lease, Liability, Current $2,708,000 USD 2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,104,000 USD -58%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,615,000 USD -7.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) $11,000 USD -70%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $704,000 USD -48%
Lessee, Operating Lease, Liability, to be Paid, Year Three $436,000 USD -61%
Deferred Tax Assets, Operating Loss Carryforwards $40,255,000 USD 28%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $9,791,000 USD 7.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $449,000 USD 3%
Operating Lease, Payments $670,000 USD -6.7%
Additional Paid in Capital $295,198,000 USD 3.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $1,798,000 USD -12%
Deferred Tax Assets, Net of Valuation Allowance $1,574,000 USD -26%
Share-based Payment Arrangement, Expense $2,246,000 USD -12%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%